Network for research on primary spine tumors
Official title: Primary Tumor Research and Outcomes Network (PTRON) A Multicenter Prospective Registry for the Management and Outcomes of Primary Tumors of the Spine
Run by AO Innovation Translation Center · NCT02790983 · Data updated 2026-11-12
This study is trying to gather information from different spine cancer centers to see how well treatments work and how they affect patients' lives.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1350 (estimated) |
| Sponsor | AO Innovation Translation Center Academic / other |
| Locations | 19 sites (Los Angeles, California and 18 other locations) |
| Status | Recruiting |
| Started | October 2016 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | February 25, 2026 |
| Trial ID | NCT02790983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients currently diagnosed with or having a history of primary spinal tumors.
✕Probably not a fit
Patients diagnosed with metastatic tumors of the spine will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project establishes a network of spine oncology centers to conduct prospective multicenter research on patients diagnosed with primary spinal column tumors. It aims to create a comprehensive clinical database that collects demographic, clinical, diagnostic, and therapeutic variables. The data will be used to investigate survival rates, local recurrence, morbidity, and health-related quality of life outcomes. By analyzing these variables, the study seeks to enhance understanding of treatment impacts and patient experiences.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with primary spinal tumors.
How similar studies have gone: Other studies focusing on registry-based approaches for cancer outcomes have shown promise, indicating potential for success in this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Patient with a current primary spine tumor or history of a primary spine tumor, including tumors within or surrounding the spinal column and/or spinal cord. This includes extradural tumors, intramedullary tumors (i.e. astrocytomas, ependymoma, etc.) and extramedullary tumors (i.e. meningiomas, neurofibromas, schwannomas, etc.). * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the registry according to the Registry Plan (RP) * Signed and dated EC/IRB approved written informed consent OR * Written consent provided according to the IRB/EC defined and approved procedures for patients who are not able to provide independent written informed consent Exclusion Criteria: \- Patient diagnosed with a metastatic tumor of the spine.
Where it's running
-
UCSF Medical Center
San Francisco, California, United States Recruiting -
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Memorial Sloan Kettering Cancer Center
New York, New York, United States Recruiting -
Rhode Island Hospital
Providence, Rhode Island, United States Recruiting
Show 13 more locations
-
The University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States Recruiting -
Vancouver General Hospital and the University of British Columbia
Vancouver, British Columbia, Canada Recruiting -
Peking University 3rd Hospital
Beijing, Beijing Municipality, China Recruiting -
Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden
Dresden, Germany Recruiting -
National Center for Spinal Disorders and Buda Health Center
Budapest, Hungary Recruiting -
Istituto Ortopedico Rizzoli
Bologna, Italy Recruiting -
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy Recruiting -
Oxford University Hospitals
Oxford, United Kingdom Recruiting -
University of California
Los Angeles, California, United States Terminated -
Memorial Sloan-Kettering Cancer Center
New York, New York, United States Withdrawn -
University of Queensland, School of Medicine
Brisbane, Australia Withdrawn -
Toronto Western Hospital
Toronto, Ontario, Canada Terminated -
Kanazawa Medical University Hospital
Kanazawa, Japan Terminated
Study contacts
- Principal investigator: Jeremy Reynolds, MD — Clinical Lead for Spinal Surgery at Oxford University Hospitals
- Study coordinator: Felix Thomas, PhD
- Email: felix.thomas@aofoundation.org
- Phone: +41 79 671 47 98
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring femoral fracture healing with a device
This study is testing a new device that helps track how well femoral fractures heal in patients using a special locking plate and a smartphone app.
-
Evaluating the performance of new clavicle plates for fractures and dislocations
This study is testing a new type of plate for fixing broken collarbones to see how well it works and how safe it is for patients over two years after surgery.
-
International registry for long bone defects after trauma
This study is creating a global database to collect information on patients with long bone injuries from trauma to help improve treatment options and outcomes.
-
Registry for patients with mandibular defects after cancer treatment
This study is collecting information from patients who have had part of their jaw removed due to cancer to see how different treatments affect their recovery and quality of life over two years.
-
Registry for patients undergoing TMJ replacement
This study is tracking around 200 patients who are getting a new jaw joint to see how the treatment affects their quality of life and what factors lead to better results over five years.
-
Registry for collecting data on periprosthetic fractures after hip and knee surgeries
This study is collecting information on how different treatments for fractures around hip and knee implants affect recovery to help improve care for patients who experience these injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.